IP Verse

Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla Gene

Patent No. EP3432882 (titled "Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla Gene") was filed by Amicus Therapeutics on Mar 15, 2017. The application was issued on Sep 1, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSMay 31, 2022D YOUNG
GILL JENNINGS & EVERYMay 31, 2022GILL JENNINGS & EVERY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3432882

AMICUS THERAPEUTICS
Application Number
EP17714100A
Filing Date
Mar 15, 2017
Status
Granted And Under Opposition
Jul 30, 2021
Publication Date
Sep 1, 2021
External Links
Slate, Register , Google Patents